Loading...
Novo Nordisk A/S
NVO•NYSE
HealthcareDrug Manufacturers - General
$65.38
$-2.36(-3.48%)
Novo Nordisk A/S (NVO) AI-Powered Stock Analysis
See how Novo Nordisk A/S scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerNovo Nordisk A/S (NVO) Stock Overall Grade
Novo Nordisk A/S’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
A
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Novo Nordisk A/S's overall stock rating.
Forecast
A+Score
97/100Financial Growth
A+Score
100/100Fundamental Growth
A+Score
100/100Key Ratios
AScore
84/100Sector Comparison
B+Score
75/100Industry Comparison
A+Score
90/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
C+Score
57/100Component Analysis Explained
Understand the key factors behind each Novo Nordisk A/S stock grade, including financials, comparisons, and forecasts.